Drug modification in the context of cancer refers to the process of altering existing drugs to enhance their effectiveness, reduce side effects, and overcome drug resistance. This can involve changes in the drug's chemical structure, formulation, delivery method, or a combination of these factors. The goal is to improve the clinical outcomes for cancer patients.